Global IPO market made a big comeback in 2017 since the financial crisis. After a grim IPO activity in 2016, the US stock market flourishes on a bull-run in 2017. There were 160 IPOs in the US in 2017 raising $35.6 billion, a rise of 89% in terms of proceeds and 52% by volume compared with 2016, according to Renaissance Capital.
Raising $3.9 billion in proceeds, Snap Inc. was the largest listing on US exchanges for 2017, becoming the first largest tech listing in the US since Alibaba in 2014 and also the largest US-based tech listing since Facebook in 2012. A perfect stage has been set for a strong IPO market in 2018 as several multi-billion dollar companies are expected to make their debut.
The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for
The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated